Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases

References

• Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 1982; 83: 563–8
   PubMed Web of Science ®Google Scholar
• Calkins BM, Mendelhoff AI. The epidemiology of idiopathic inflammatory bowel diseases. Inflammatory bowel diseases, JB Kirsner, RG Shorter. Williams & Wilkins, Baltimore, Md 1995; 31–68
   Google Scholar
• Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 84–8
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767–73
   PubMed Web of Science ®Google Scholar
• Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Belaiche J, et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001; 120: 816–9
   PubMed Web of Science ®Google Scholar
• Orholm M, Iselius L, Sorensen TI, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. Br Med J 1993; 306: 20–4
   PubMedGoogle Scholar
• Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821–3
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001; 276: 4812–8
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA, Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91: 295–8
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock HW. Molecular mechanism in tolerance to lipopolysaccharide. J Inflam 1995; 45: 13–26
   PubMedGoogle Scholar
• Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000; 164: 3476–9
   PubMed Web of Science ®Google Scholar
• Kastenbauer S, Ziegler-Heitbrock HW. NF-kappaB1 (p50) is up-regulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect Immun 1999; 67: 1553–9
   PubMedGoogle Scholar
• Goldring CE, Reveneau S, Pinard D, Jeannin JF. Hyporesponsiveness to lipopolysaccharide alters the composition of NF-kappaB binding to the regulatory regions of inducible nitric oxide synthase gene. Eur J Immun 1998; 28: 2960–70
   PubMedGoogle Scholar
• Kobayashi K, Hernandez LD, Galan JE, Janeway CA, Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191–202
   PubMed Web of Science ®Google Scholar
• Nakayama K, Okugawa S, Yanagimoto S, Kitazawa T, Tsukada K, Kawada M, et al. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J Biol Chem 2004; 279: 6629–34
   PubMedGoogle Scholar
• Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Gen 1996; 14: 199–202
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–29
   PubMed Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365–86
   PubMedGoogle Scholar
• Beckmann L, Fischer C, Deck KG, Nolte IM, te Meerman G, Chang-Claude J, et al. Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex genetic trait. Genet Epidemiol 2001; 21 Suppl 1: S554–9
   Google Scholar
• Boon M, Nolte IM, Bruinenberg M, Spijker GT, Terpstra P, Raelson J, et al. Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 2001; 3: 221–30
   PubMedGoogle Scholar
• Levinson DF, Kirby A, Slepner S, Nolte I, Spijker GT, te Meerman G. Simulation studies of detection of a complex disease in a partially isolated population. Am J Med Genet 2001; 105: 65–70
   PubMedGoogle Scholar
• Nolte IM, Spijker GT, Boon M, Spijker GT, Terpstra P, Raelson J, , et al. The haplotype sharing statistic: fine-mapping of disease gene loci by comparing patients and controls for the length of haplotype sharing. [Thesis] Groningen, The Netherlands: IM Nolte, 2002 2002.
   Google Scholar
• de Jong MM, Nolte IM, de Vries EG, Schaapveld M, Kleibeuker JH, Oosterom E, , et al. The HLA class III subregion is responsible for an increased breast cancer risk. Hum Mol Genet 2003;12:2311–9.
   PubMedGoogle Scholar
• Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, et al. Association Between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 567–75
   PubMed Web of Science ®Google Scholar
• Lewontin R. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49–67
   PubMed Web of Science ®Google Scholar
• Rogler G. Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2004; 20: 311–7
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800–8
   PubMed Web of Science ®Google Scholar
• Escoll P, del Fresno C, Garcia L, Valles G, Lendinez MJ, Arnalich F, et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003; 311: 465–72
   PubMed Web of Science ®Google Scholar